A M Wu

Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange.

A A Raubitschek, A. Wu, M. Sherman, 2001, Protein engineering.

Numerical selection of optimal tumor imaging agents with application to engineered antibodies.

L E Williams, A A Raubitschek, J. Wong, 2001, Cancer biotherapy & radiopharmaceuticals.

High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.

S S Gambhir, M E Phelps, L E Williams, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.

J M Esteban, L E Williams, A A Raubitschek, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.

J M Esteban, L E Williams, M. Neumaier, 1995, Cancer research.

Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications.

A A Raubitschek, A. Wu, J. Shively, 2001, Journal of immunological methods.

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.

L E Williams, R Fischer, M. Neumaier, 1996, Immunotechnology : an international journal of immunological engineering.

Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.

J M Esteban, L E Williams, A A Raubitschek, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

L E Williams, J. Wong, A. Wu, 1996, Cancer research.